ABT long through 110 Post earnings set up. This looks good through 110. It looks like earnings are strong as well. With the overall market taking a dip this stock is holding up really well. I will look to enter on Monday.
ABT trade ideas
Buy if we break 110 with Volume at the opening of the market Target 1 : 111.50
Target 2 : 114
** Disclaimer ** the content on this analysis is subject to change at any time without notice, and is provided for the sole purpose of assisting traders to make independent investment decisions
Abt pt 110Abt , look at last few candles. Earning soon covid is not going away. Few rapid test got approved past few weeks. We are taking off
weekly analysis of ABBOTT LABORATORIES Hi friends
the weekly chart of this market shows that it will know with a high probability after the breakout at the 85.06 level that the next target is 115.31
therefore in the medium term there would be an upward trend
please subscribe to receive more analyzes
Thank you
ABBOT Covid Winner Billions of Rapid testsOpened a very long long on ABBOT. Abbot is the company that will profit more from COVID for the next 2 years.Short term play November spread 110c/115c, IV very low, great risk reward ratio.
PT1: 110
PT2:115
There is no stop,I dont think will ever go lower than 100$ again.
$ABT can fall in the next daysContextual immersion trading strategy idea.
Abbott Laboratories discovers, develops, manufactures, and sells health care products.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price in the next days.
So I opened a short position from $100,92;
stop-loss — $103,53.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
daily analysis of ABBOTT LABORATORIES Hi friends
the daily chart of this market shows with a high probability an uptrend in the next days but at the same time it is better to be vigilant of the change of direction towards the opposite please subscribe to receive more analysis
COVID-19 TEST RECEIVES FDA EMERGENCY USE AUTHORIZATIONABBOTT'S FAST, $5, 15-MINUTE, EASY-TO-USE COVID-19 ANTIGEN TEST RECEIVES FDA EMERGENCY USE AUTHORIZATION; MOBILE APP DISPLAYS TEST RESULTS TO HELP OUR RETURN TO DAILY LIFE; RAMPING PRODUCTION TO 50 MILLION TESTS A MONTH
- Abbott's BinaxNOW™ COVID-19 Ag Card is a rapid, reliable, highly portable, and affordable tool for detecting active coronavirus infections at massive scale
- Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5% in clinical study
- Abbott to offer a no-charge complementary phone app, which allows people to display their BinaxNOW test results when asked by organizations where people gather, such as workplaces and schools
- Company will ship tens of millions of tests in September, ramping to 50 million tests a month at the beginning of October
-Abbott will sell this test for $5
-Abbott will ship tens of millions of tests in September, ramping to 50 million tests a month at the beginning of October. The company has invested hundreds of millions of dollars since April in two new U.S. facilities to manufacture BinaxNOW at massive scale.
abbott.mediaroom.com
This is not a test for asymptomatic people. I’ll perk up when the asymptomatic test launches.
twitter.com
$ABT Abbott Labs $125
Having missed out on this move pre-market, its maybe
wise to wait for the Fibonacci resistance to break @ $116.32.
1-2-1 extension target is then $124.54
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$ABT Cup and Handle Pattern Formation on DailySentiment: Bullish
Reasons: Technical Analysis & News Catalyst
News has just been released that $ABT has been approved by the U.S to begin working on a 5$ rapid COVID-19 antigen test. I find this to be huge considering the inconvenience in searching for a COVID testing facility in certain places in the U.S as well as the discomfort associated with the actual process. In addition price action is just nice if Im being honest. It has underwent a long series of consolidation and converging trendlines and is due for a breakout.
